Commentary

Podcast

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Author(s):

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.

On this episode of Managed Care Cast, we're talking with Sreekanth Chaguturu, MD, the chief medical officer of CVS Health.

We discuss the impact of recent pharmaceutical innovations, namely glucagon-like peptide-1 (GLP-1) receptor agonists and biosimilars, on patient health outcomes. Also, we explore the role of trust between patients and providers in adopting new medications, along with initiatives used to reduce drug prices and improve access.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Screenshot of an interview with Adam Colborn, JD
Screenshot of Stephanie Hsia, PharmD
Cesar Davila-Chapa, MD
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Io Hui, PhD, researcher at The University of Edinburgh
Corey McEwen, PharmD, MS
Jonathan Kurman, MD
Krunal Patel, MD
Related Content
The homepage of CMS.gov is seen on a smartphone | Tada Images - stock.adobe.com
October 30th 2024

Medicare Shared Savings Program Continues to Deliver Savings, Quality Care

Pearl Steinzor
Program yields largest savings in its history of more than $2.1 billion in 2023.
Managed Care Cast
October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
The Need for Regulation to Positively Impact Drug Formulary Decisions to Ensure Appropriate Patient Access: A Little-Discussed Topic in Pharmaceutical Policy and Pricing Debate
October 30th 2024

The Need for Regulation to Positively Impact Drug Formulary Decisions to Ensure Appropriate Patient Access: A Little-Discussed Topic in Pharmaceutical Policy and Pricing Debate

Jan E. Berger, MD, MJ
As health care moves toward a value-based payment model, the pharmacy benefit is going in the opposite direction, one that places unit cost over clinical appropriateness.
managed care cast logo
October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Self-injurious thoughts and behaviors are not as well-detected in younger patients | image credit: Pro Hi-Res - stock.adobe.com
October 29th 2024

More Accurate Detection of Self-Injurious Behavior Needed for Minoritized Youth

Kyle Munz
A recent retrospective, cross-sectional study found that detecting self-injurious thoughts and behaviors in youth requires improvement to ensure equitable identification of at-risk patients.
Retired woman counting coins | Image Credit: © manassanant-stock.adobe.com
October 28th 2024

Medicare Costs Push Financial Limits of Many Older Adults

Maggie L. Shaw
Patients with Medicare coverage and whose incomes fall between 100% and 400% or less of the federal poverty level may find themselves in a tricky financial situation concerning their ability to pay the Medicare Part A hospital deductible.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo